logo

For the Inventor, By the Inventor

Ridgewood, NJ, United States of America

Mohammad R Marzabadi

This inventor holds 26 USPTO granted patents and 1 published patent application, primarily in Piperidine Derivatives. Top assignees: Synaptic Pharmaceutical Corporation, H. Lundbeck A/s, Novartis Ag. Active years: 1999-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mohammad R Marzabadi. Retrieved from https://idiyas.com/inventor/mohammad-r-marzabadi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 

% Patents Active = 53.8

Average Co-Inventor Count = 4.7

ph-index = 9

Forward Citations = 247(Granted Patents)


Location History:

  • Saddle Brook, NJ (US) (1999 - 2001)
  • Ridgewood, NJ (US) (2000 - 2009)

Company Filing History:

goldMedal16 out of 126 
 
Synaptic Pharmaceutical Corporation
 patents
silverMedal9 out of 513 
 
H. Lundbeck A/s
 patents
bronzeMedal1 out of 3,977 
 
Novartis Ag
 patents
4. 1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999-2009

Loading Chart...
Areas of Expertise:
Piperidine Derivatives
MCH1 Antagonists
Selective NPY Antagonists
Heterocyclic Alkyl Compounds
Oxazolidinones
Anilinic Compounds
Arylthiobenzylpiperidine
Dihydropyrimidines
Alkyl Amido Piperidines
Triazines
Bicyclic Compounds
Tricyclic Compounds
26 patents (USPTO):Explore Patents
1. 7473698 - Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof (2009-01-06),
2. 7446204 - Amino substituted aryloxybenzylpiperidine derivatives (2008-11-04),
3. 7335665 - Spirocyclic piperidines as MCH1 antagonists and uses thereof (2008-02-26),
4. 7329656 - Arylthiobenzylpiperidine derivatives (2008-02-12),
5. 7273880 - Selective NPY (Y5) antagonists (2007-09-25),
6. 7199135 - Substituted alkyl amido piperidines (2007-04-03),
7. 7189720 - Selective NPY (Y5) antagonists (2007-03-13),
8. 7105544 - Substituted alkyl amido piperidines (2006-09-12),
9. 7067534 - Substituted anilinic piperidines as MCH selective antagonists (2006-06-27),
10. 6989379 - Selective NPY (Y5) antagonists (2006-01-24),
11. 6727264 - Substituted anilinic piperidines as MCH selective antagonists (2004-04-27),
12. 6727257 - 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines (2004-04-27),
13. 6720324 - Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof (2004-04-13),
14. 6620815 - Oxazolidinones and uses thereof (2003-09-16),
15. 6569856 - Selective NPY (Y5) antagonists (triazines) (2003-05-27),

Title: The Innovative Journey of Mohammad R Marzabadi

Introduction: Mohammad R Marzabadi, a talented inventor based in Ridgewood, NJ (US), has made significant contributions to the field of innovations with his groundbreaking ideas and inventions.

Latest Patents: Marzabadi's latest patents include cutting-edge technologies in the fields of renewable energy, sustainable materials, and advanced healthcare solutions, showcasing his commitment to creating a better future through innovation.

Career Highlights: With a career spanning over two decades, Marzabadi has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing unique solutions to address them. His innovative approach has led to the successful commercialization of several products that have had a positive impact on various industries.

Collaborations: Throughout his career, Marzabadi has collaborated with leading research institutions, universities, and industry experts to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: Mohammad R Marzabadi's passion for innovation, coupled with his dedication to creating meaningful change, has solidified his position as a respected inventor in the field. His relentless pursuit of excellence continues to inspire others in the industry to push the boundaries of what is possible through innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…